Nugrahanto Andika Priamas, Triono Agung, Damroni Rais Aliffandy, Herini Elisabeth Siti
Division of Paediatric Neurology, Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Ann Indian Acad Neurol. 2024 Jul 1;27(4):371-377. doi: 10.4103/aian.aian_384_24. Epub 2024 Aug 16.
Bacterial meningoencephalitis presents significant diagnostic and therapeutic challenges with high morbidity and mortality in pediatric populations worldwide. The early and precise identification of the etiology of these infections is essential for effective treatment and better patient results. Traditional diagnostic methods, while effective, can be time-consuming. This manuscript aims to evaluate the accuracy of serum procalcitonin (PCT), cerebrospinal fluid (CSF) neutrophil-to-lymphocyte ratio (NLR), and CSF lactate as biomarkers in pediatric bacterial meningoencephalitis.
From March 2021 to November 2023, a cross-sectional study was conducted at Dr. Sardjito General Hospital, a tertiary referral hospital in Yogyakarta, Indonesia. One hundred ninety-seven patients underwent complete clinical and laboratory examinations before being divided into bacterial and non-bacterial groups based on CSF culture results and cytochemical profiles. The diagnostic accuracy was evaluated by the receiver operating characteristic curve using Statistical Package for the Social Sciences.
Serum PCT, CSF NLR, and CSF lactate levels showed a notable increase in the bacterial meningoencephalitis group (mean = 4.63 ± 5.52 ng/ml, 4.39 ± 6.68, and 3.59 ± 2.38 mmol/l, respectively) compared to the viral/aseptic group (mean = 0.51 ± 0.88 ng/ml, 0.33 ± 0.95, and 2.25 ± 2.33 mmol/l, respectively) ( P < 0.001). Serum PCT and CSF NLR combined measurement had high sensitivity (86.4%) and specificity (88.6%), with an area under the curve of 0.929 (95% confidence interval, 0.873-0.985), surpassing other tested biomarkers.
The findings suggest that combining serum PCT and CSF NLR could be beneficial for early diagnosis, potentially allowing timely, targeted treatment and differentiating between bacterial and non-bacterial infections, ultimately improving patient outcomes.
细菌性脑膜脑炎在全球儿科人群中带来了重大的诊断和治疗挑战,其发病率和死亡率都很高。尽早准确识别这些感染的病因对于有效治疗和改善患者预后至关重要。传统诊断方法虽然有效,但可能耗时较长。本论文旨在评估血清降钙素原(PCT)、脑脊液(CSF)中性粒细胞与淋巴细胞比值(NLR)以及脑脊液乳酸作为小儿细菌性脑膜脑炎生物标志物的准确性。
2021年3月至2023年11月,在印度尼西亚日惹一家三级转诊医院——萨迪托综合医院开展了一项横断面研究。197例患者在接受全面的临床和实验室检查后,根据脑脊液培养结果和细胞化学特征分为细菌感染组和非细菌感染组。使用社会科学统计软件包通过受试者工作特征曲线评估诊断准确性。
与病毒/无菌性感染组相比(分别为均值 = 0.51 ± 0.88 ng/ml、0.33 ± 0.95和2.25 ± 2.33 mmol/l),细菌性脑膜脑炎组的血清PCT、脑脊液NLR和脑脊液乳酸水平显著升高(分别为均值 = 4.63 ± 5.52 ng/ml、4.39 ± 6.68和3.59 ± 2.38 mmol/l)(P < 0.001)。血清PCT和脑脊液NLR联合检测具有高敏感性(86.4%)和特异性(88.6%),曲线下面积为0.929(95%置信区间,0.873 - 0.985),超过其他检测的生物标志物。
研究结果表明,联合检测血清PCT和脑脊液NLR可能有助于早期诊断,有可能实现及时、有针对性的治疗,并区分细菌感染和非细菌感染,最终改善患者预后。